Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 1,285,200 | 1,355,200 | 1,524,300 | 1,544,600 | 1,081,600 |
| Cost of Goods | 724,100 | 754,000 | 904,300 | 894,300 | 603,200 |
| Gross Profit | 561,100 | 601,200 | 620,000 | 650,300 | 478,400 |
| Operating Expenses | 472,200 | 505,000 | 503,400 | 496,100 | 338,800 |
| Operating Income | 89,000 | 96,200 | 116,900 | 154,500 | 139,800 |
| Interest Expense | 19,400 | 21,000 | 21,700 | -100 | 24,400 |
| Other Income | 42,100 | -156,100 | 1,900 | 1,100 | 3,200 |
| Pre-tax Income | 111,700 | -80,900 | 97,100 | 155,700 | 118,600 |
| Income Tax | 35,000 | -18,700 | 42,300 | 61,500 | 50,900 |
| Net Income Continuous | 76,700 | -62,200 | 54,800 | 94,200 | 67,700 |
| Minority Interests | N/A | N/A | N/A | -600 | -400 |
| Net Income | $76,700 | $-62,200 | $54,800 | $94,800 | $68,100 |
| EPS Basic Total Ops | 0.61 | -0.49 | 0.44 | 0.76 | 0.55 |
| EPS Basic Continuous Ops | 0.61 | -0.49 | 0.44 | 0.76 | 0.54 |
| EPS Diluted Total Ops | 0.60 | -0.49 | 0.43 | 0.74 | 0.54 |
| EPS Diluted Continuous Ops | 0.60 | -0.49 | 0.43 | 0.74 | 0.53 |
| EBITDA(a) | $215,500 | $235,400 | $269,200 | $353,600 | $233,300 |